CIK: 0001542339 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 4, 2026
Total Value ($000): $318,280 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TELA | TELA BIO INC | 7,714,709 (+87.7%) | $9,103 (+48.6%) | 2.9% | $6.89 | -81.6% | COM | 872381108 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BVS | BIOVENTUS INC | 13,021,324 | $96,879 | 30.4% | $13.37 | -46.2% | COM CL A | 09075A108 |
| MDXG | MIMEDX GROUP INC | 28,195,249 | $190,882 | 60.0% | $7.32 | -4.3% | COM | 602496101 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 1,084,857 | $19,820 | 6.2% | $4.68 | +202.7% | COM NEW | 30233G209 |
| VERO | VENUS CONCEPT INC | 99,021 | $147 | 0.0% | $3.59 | -43.5% | COM | 92332W303 |
| MNOV | MEDICINOVA INC | 1,105,941 | $1,449 | 0.5% | $2.95 | -53.2% | COM NEW | 58468P206 |